Details of the Drug
General Information of Drug (ID: DMMIZWE)
| Drug Name |
piperidine-4-sulphonic acid
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
piperidine-4-sulfonic acid; Piperidine-4-sulphonic acid; 4-Piperidinesulfonic acid; 72450-62-5; CHEMBL34155; P4S; C5H11NO3S; AC1Q6WTY; Lopac-P-9159; AC1L1J2H; Lopac0_001024; MLS000069699; SCHEMBL106762; GTPL4287; DTXSID70222752; Piperidine-4-sulfonic acid (P4S); ZINC2516028; FCH838660; MFCD00055097; BDBM50087272; AKOS006272381; API0008543; CCG-205104; NCGC00093348-02; NCGC00015855-04; NCGC00093348-03; NCGC00015855-01; NCGC00015855-03; NCGC00015855-02; SMR000058505; DA-17251; AB1009736; LS-176970; FT-0688685; EU-0101024; P 9159
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL is unavailable | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 165.21 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -3 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||
References


